Dr. Mercola's Censored Library (Private Membership)

Share this post
FDA Gives Accelerated Approval for Risky Alzheimer’s Pill
takecontrol.substack.com

FDA Gives Accelerated Approval for Risky Alzheimer’s Pill

The Alzheimer's medication Leqembi received fast-tracked approval even though it causes life-threatening adverse events and is targeting a component of the disease that many believe is misunderstood.

Dr. Joseph Mercola
Jan 25
11
Share this post
FDA Gives Accelerated Approval for Risky Alzheimer’s Pill
takecontrol.substack.com
fda gives approval for risky alzheimers pill

STORY AT-A-GLANCE

  • The U.S. Food and Drug Administration (FDA) granted accelerated approval for the Alzheimer’s disease drug lecanemab (Leqembi)

  • The drug, a monoclonal antibody, binds to amyloid beta in the brain

  • The most common reactions included amyloid-related imaging abnormalities, or ARIA, which involves swelling and bleeding in the brain that can be l…

Keep reading with a 7-day free trial

Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2023 Dr. Joseph Mercola
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing